Interaction of the tyrosine phosphatase SHP-2 with Gab2 regulates Rho-dependent activation of the c-fos serum response element by interleukin-2

Por Arnaud, Mary, Mzali, Rym, Gesbert, Franck, Crouin, Catherine, Guenzi, Christine, Vermot-Desroches, Claudine, Wijdenes, John, Courtois, Geneviève, Bernard, Olivier, Bertoglio, Jacques
Publicado em 2004

Due to interleukin-6 type cytokine redundancy only glycoprotein 130 receptor blockade efficiently inhibits myeloma growth

Por Burger, Renate, Günther, Andreas, Klausz, Katja, Staudinger, Matthias, Peipp, Matthias, Penas, Eva Maria Murga, Rose-John, Stefan, Wijdenes, John, Gramatzki, Martin
Publicado no Haematologica (2017)

Syndecan-1 antigen, a promising new target for triple-negative breast cancer immuno-PET and radioimmunotherapy. A preclinical study on MDA-MB-468 xenograft tumors

Por Rousseau, Caroline, Ruellan, Anne Lise, Bernardeau, Karine, Kraeber-Bodéré, Françoise, Gouard, Sebastien, Loussouarn, Delphine, Saï-Maurel, Catherine, Faivre-Chauvet, Alain, Wijdenes, John, Barbet, Jacques, Gaschet, Joëlle, Chérel, Michel, Davodeau, François
Publicado em 2011

A new anti-mesothelin antibody targets selectively the membrane-associated form

Por Asgarov, Kamal, Balland, Jeremy, Tirole, Charline, Bouard, Adeline, Mougey, Virginie, Ramos, Diana, Barroso, António, Zangiacomi, Vincent, Jary, Marine, Kim, Stefano, Gonzalez-Pajuelo, Maria, Royer, Bernard, de Haard, Hans, Clark, Andy, Wijdenes, John, Borg, Christophe
Publicado no MAbs (2017)